Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Neumann-Haefelin

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
Journal of Hepatology|August 27, 2019
Paving the way for T cell-based immunotherapies in chronic hepatitis EChristoph Neumann-Haefelin
Current Opinion in Rheumatology|May 10, 2013
HLA-B27-mediated protection in HIV and hepatitis C virus infection and pathogenesis in spondyloarthritis: two sides of the same coin?Christoph Neumann-Haefelin
The Journal of Clinical Investigation|January 3, 2023
Liver-resident CD8+ T cells in viral hepatitis: not always good guysHendrik Luxenburger, Christoph Neumann-Haefelin
Current Topics in Microbiology and Immunology|March 7, 2013
Adaptive immune responses in hepatitis C virus infectionChristoph Neumann-Haefelin, Robert Thimme
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|January 13, 2022
[Chronic hepatitis B virus infection: current and future treatment strategies]Christoph Neumann-Haefelin, Robert Thimme
Hepatology (Baltimore, Md.)|April 14, 2026
Two decades of Hepatitis E in solid organ transplantation: From endemic insight to unresolved therapeutic questionsPatrick Behrendt, Christoph Neumann-Haefelin
Gut|September 5, 2025
T cells engineered to carry a high-affinity HBV-specific T cell receptor: a potent weapon against advanced HBV-related HCCRobert Thimme, Christoph Neumann-Haefelin
The Journal of Clinical Investigation|September 18, 2018
Entering the spotlight: hepatitis B surface antigen-specific B cellsChristoph Neumann-Haefelin, Robert Thimme
Hepatology (Baltimore, Md.)|May 19, 2023
Deciphering the role of soluble ORF2 protein in virus-host interaction in HEV infectionMichelle Maas, Christoph Neumann-Haefelin
Gut|June 21, 2014
Prediction of clinical outcome in advanced hepatitis C-associated liver disease: identification of patients at the highest need for antiviral treatment and surveillanceChristoph Neumann-Haefelin, Robert Thimme
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
Journal of Hepatology|August 27, 2019
Paving the way for T cell-based immunotherapies in chronic hepatitis EChristoph Neumann-Haefelin
Current Opinion in Rheumatology|May 10, 2013
HLA-B27-mediated protection in HIV and hepatitis C virus infection and pathogenesis in spondyloarthritis: two sides of the same coin?Christoph Neumann-Haefelin
The Journal of Clinical Investigation|January 3, 2023
Liver-resident CD8+ T cells in viral hepatitis: not always good guysHendrik Luxenburger, Christoph Neumann-Haefelin
Current Topics in Microbiology and Immunology|March 7, 2013
Adaptive immune responses in hepatitis C virus infectionChristoph Neumann-Haefelin, Robert Thimme
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|January 13, 2022
[Chronic hepatitis B virus infection: current and future treatment strategies]Christoph Neumann-Haefelin, Robert Thimme
Hepatology (Baltimore, Md.)|April 14, 2026
Two decades of Hepatitis E in solid organ transplantation: From endemic insight to unresolved therapeutic questionsPatrick Behrendt, Christoph Neumann-Haefelin
Gut|September 5, 2025
T cells engineered to carry a high-affinity HBV-specific T cell receptor: a potent weapon against advanced HBV-related HCCRobert Thimme, Christoph Neumann-Haefelin
The Journal of Clinical Investigation|September 18, 2018
Entering the spotlight: hepatitis B surface antigen-specific B cellsChristoph Neumann-Haefelin, Robert Thimme
Hepatology (Baltimore, Md.)|May 19, 2023
Deciphering the role of soluble ORF2 protein in virus-host interaction in HEV infectionMichelle Maas, Christoph Neumann-Haefelin
Gut|June 21, 2014
Prediction of clinical outcome in advanced hepatitis C-associated liver disease: identification of patients at the highest need for antiviral treatment and surveillanceChristoph Neumann-Haefelin, Robert Thimme
Pageof 15